Jim Tananbaum is the founding CEO of Foresite Capital Management. Foresite Capital Management is a private dedicated healthcare equity firm. Its aim is to identify healthcare leaders and supply them with capital, networks, and information to grow their profitability. He co-founded two biopharmaceutical companies and two healthcare investment practices before founding the Foresight Capital. Geltex Pharmaceuticals brought two drugs to the market for less than 80 million dollars. Renagel(Renzela) had an annual revenue rate of more than 200 million dollars. It was acquired for 1.6 billion dollars in 1998. The drug produces approximately 1 billion dollars per annum. He also co-founded and was the CEO of Thearavance, Inc. According to INC42, he was a partner at Sierra Ventures and helped to establish its healthcare services investment practice. He later became a founding partner of Prospect Venture Partners II and III. He has led 21 investments including Amira Pharmaceuticals, Ameri Group, Healthon, and Jazz.
Jim Tananbaum founded Foresite Capital after 25 years of being a healthcare entrepreneur. Antarcia is one of the largest Foresight investment projects. It is a twice a year type II diabetes implant that helps the patients to control the condition and also lose weight. The firm has also invested in Aeri Pharmaceuticals to bring a daily glaucoma treatment to the market. His key elements to success are innovation and the team of effective thought leaders in healthcare. Foresite has sponsored many emerging healthcare leaders in biopharmaceuticals, diagnostics, and Genomic Sequencing.
According to Biz Journals, Jim Tananbaum attained his MD and MBA from Harvard and MS from MIT. He studied Math and Electrical Engineering/Computer Science at Yale University. He co-founded and was the CEO of Geltex Pharmaceuticals. It was bought by Genzyme/Sanofi immediately after finishing business school. He is particularly intrigued by research on the science behind health care innovation to solve unmet healthcare needs. He is an academician at heart and has an unbridled commitment to finding the best solutions that science has to offer in healthcare. Innovation is an ideal concept for business growth. Jim has always considered it in all his investments.